The occurrence of extended-spectrum β-lactamase producing Shigella spp. in Tehran, Iran


Background and Objectives: The emergence of extended-spectrum β-lactamase (ESBL)-producing Shigella spp.  is of increasing clinical concern specially in children worldwide. The aim of this study was to investigate the occurrence of extended-spectrum β-lactamase producing Shigella spp. in Tehran, Iran.
Materials and Methods: The study included all Shigella isolates recovered from pediatric patients aged less than 12 years admitted to a major pediatric hospital in Tehran, Iran, from 2008 to 2010. Bacterial identification, antimicrobial susceptibility testing, extended spectrum β-lactamases (ESBLs) screening and confirmatory tests were performed according to the standard guidelines. Conjugal transfer experiments and plasmid analysis were also carried out. Polymerase chain reaction and sequencing were used to identify the genetic determinants responsible for ESBL production.
Results: Four out of 55 Shigella isolates, including three S. sonnei and one S. flexneri, showed an ESBL-positive phenotype. Plasmid transfer of the ESBL phenotype was successful for the S. flexneri isolate only. By PCR and sequencing, one S. sonnei isolate tested positive for the CMY-59 gene, while the other two S. sonnei and the S. flexneri isolates tested positive for the bla  CTX-M-15 genes.
Conclusion: We found the prevalence of ESBL producing Shigella isolates was higher than detection rates observed in many other countries. Our finding raise concerns about the dissemination of ESBL among the strains of endemic S. sonnei throughout the country, because this species is now the most frequently isolated Shigella species in Iran and shigellosis by such strains in the community can pose a significant threat to patients and presents a challenge for disease management.

Ranjbar R, Hosseini MJ, Kaffashian AR, Farshad S. An outbreak of shigellosis due to Shigella flexneri serotype 3a in a prison in Iran. Arch Iran Med 2010; 13: 413-416.

Filliol-Toutain I, Chiou CS, Mammina C, Gerner-Smidt P, Thong KL, Phung DC, et al. Global distribution of Shigella sonnei clones. Emerg Infect Dis 2011; 17:1910-2.

Zhang R, Zhou HW, Cai JC, Zhang J, Chen GX, Nasu M, et al. Serotypes and extended-spectrum β-lactamase types of clinical isolates of Shigella spp. from the Zhejiang province of China. Diagn Microbiol Infect Dis 2011; 69: 98-104.

Ahamed J, Kundu M. Molecular characterization of the SHV-11 β- lactamase of Shigella dysenteriae. Antimicrob Agents Chemother 1999; 43: 2081-2083.

Folster JP, Pecic G, Krueger A, Rickert R, Burger K, Carattoli A, Whichard JM. Identification and characterization of CTX-M-producing Shigella isolates in the United States. Antimicrob Agents Chemother 2010; 54: 2269-2270.

Lartigue MF, Poirel L, Decousser JW, Nordmann P.Multidrug- Resistant Shigella sonnei and Salmonella enterica serotype Typhimurium isolates producing CTX-M β-lactamases as causes of community- acquired infection in France. Clin Infect Dis 2005; 40: 1069-1071.

Acikgoz ZC, Gulay Z, Bicmen M, Gocer S, Gamberzade S. CTX-M-3 extended-spectrum beta-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand J Infect Dis 2008; 35: 503-505.

Matar GM, Jaafar R, Sabra A, Hart CA, Corkill JE, Dbaibo GS, Araj GF. First detection and sequence analysis of the bla -CTX-M-15 gene in Lebanese isolates of extended-spectrum-lactamase-producing Shigella sonnei. Ann Trop Med Parasitol 2007; 101: 511-517.

Rahman M, Shoma S, Rashid H, Siddique AK, Nair GB, Sack DA. Extended-spectrum beta-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh. J Antimicrob Chemother 2004;54: 846-847.

Cheung TK, Chu YW, Tsang GK, Ngan JY, Hui IS, Kam KM. Emergence of CTX-M-type beta-lactam resistance in Shigella spp. in Hong Kong. Int J Antimicrob Agents 2005; 25: 350-352.

Xiong Z, Li T, Xu Y, Li J. Detection of CTX-M-14 extended-spectrum beta-lactamase in Shigella sonnei isolates from China. J Infect 2007; 55: e125-128.

Ranjbar R, Aleo A, Giammanco GM, Dionisi AM, Sadeghifard N, Mammina C. Genetic relatedness among isolates of Shigella sonnei carrying class 2 integrons in Tehran, Iran, 2002 – 2003. BMC Infect Dis 2007; 22: 62.

Ranjbar R, Soltan-Dallal, MM, Pourshafie MR.

Antibiotic resistance among Shigella serogroups isolated in Tehran, Iran (2002-2004). J Infect Dev Ctries 2009;3: 647-648.

Hosseini MJ, Ranjbar R, Ghasemi H, Jalalian HR. The prevalence and antibiotic resistance of Shigella spp. recovered from patients admitted to Bouali Hospital, Tehran, Iran during 1999-2000. Pak J BiolSci 2007; 10:2778-2780.

Soltan-Dallal MM, Ranjbar R, Pourshafie MR. The study of antimicrobial resistance among Shigella flexneri strains isolated in Tehran, Iran. J Pediatr Infect Dis 2011; 6 : 125-129.

Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken FC, editors. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology;1995. p. 1, 482.

Clinical and Laboratory Standards Institute (CLSI). (2008): Performance standards for antimicrobial susceptibility testing: 17th informational supplement (M100-S17). Wayne, PA: CLSI.

Clinical and Laboratory Standard Institute, 2006.Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. CLSIdocument M100-S16. CLSI, Wayne, Pa.

Tan TY, Ng LS, He J, Koh TH, Hsu LY. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob Agents Chemother 2009; 53: 146-149.

Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010;65: 490-495.

Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 1979; 7 : 1513-1523.

Ranjbar R, SoltanDallal MM, Talebi M, Pourshafie MR. Increased isolation and characterization of Shigella sonnei obtained from hospitalized children in Tehran, Iran. J Health Popul Nutr 2008; 26: 426-430.

Mohammadi-Mehr M, Feizabadi MM. Antimicrobial resistance pattern of Gram-negative bacilli isolated from patients at ICUs of Army hospitals in Iran. Iran J Microbiol 2011; 3: 26-30.

Tajbakhsh M, GarcíaMigura L, Rahbar M, Svendsen CA, Mohammadzadeh M, Zali MR, Aarestrup FM, Hendriksen RS. Antimicrobial-resistant Shigella infections from Iran: an overlooked problem? J Antimicrob Chemother 2012 ;67: 1128-1133.

Hong SJ, Lee CH, Wang JH, Song W, Jung SH. Clinical characteristics of extended-spectrum β-lactamase producing Shigella sonnei infection outbreaked in Chungju area. Korean J Lab Med 2006; 26: 168-73.

Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, Chiou CC. Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC - lactamase resistance in S. sonnei. J Clin Microbiol 2005; 43:2608-2612.

Sabra AH, Araj GF, Kattar MM, Abi-Rached RY, Khairallah MT, Klena JD, et al. Molecular charac- terization of ESBL-producing Shigella sonnei isolates from patients with bacilliary dysentery in Lebanon. J Infect Dev Ctries 2009;3: 300-305.

Upton A, Mohiuddin J, Bathgate T, Taylor S, Simmons G, Woodhouse R, Heffernan H. High prevalence of CTX- M-15 extended-spectrum b-lactamase among contacts of patients with shigellosis due to Shigella flexneri carrying CTX-M-15. J Antimicrob Chemother 2007;60: 906-908.

IssueVol 5 No 2 (2013) QRcode
Antibiotic resistance ESBLs Shigella spp

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Ranjbar R, Ghazi F-M, Farshad S, Giammanco G-M, Aleo A, Owlia P, Jonaidi N, Sadeghifard N, Mammina C. The occurrence of extended-spectrum β-lactamase producing Shigella spp. in Tehran, Iran. Iran J Microbiol. 1;5(2):108-112.